Naini Thaker is an Assistant Editor at Forbes India, where she has been reporting and writing for over seven years. Her editorial focus spans technology, startups, pharmaceuticals, and manufacturing. Prior to Forbes India, she worked at Outlook Business. Beyond the newsroom, Naini regularly emcees events and moderates panel discussions.
NewsIndia’s cough syrup deaths raise concerns over drug safety standards
Contaminated cough syrup has exposed deep cracks in India’s drug safety net—raising questions about regulatory gaps and highlighting the need for systemic change
...
Advertisement
Advertisement
Advertisement